List of articles with "Gilead Sciences"

Gilead's New HIV Treatment

Gilead's New HIV Treatment

USA Foster City Gilead Sciences Biktegravir Rilpivirine
Gilead's Rainbow Win

Gilead's Rainbow Win

Japan Tokyo LGBTQ+ Gilead Sciences PRIDE Index
Gilead's Q3 2025 Earnings

Gilead's Q3 2025 Earnings

United States Foster City Trodelvy Gilead Sciences Veklury
Trodelvy in TNBC

Trodelvy in TNBC

USA TNBC Foster City Trodelvy Gilead Sciences
Gilead CAR T Program

Gilead CAR T Program

Japan Tokyo CAR T Therapy Gilead Sciences Kite Pharma
Gilead's HIV GAP6 Site

Gilead's HIV GAP6 Site

Japan Tokyo HIV Awareness Gilead Sciences HIV/AIDS GAP6
HHP and Gilead Deal

HHP and Gilead Deal

Hong Kong Gilead Sciences Encequidar Health Hope Pharma
HHP and Gilead Deal

HHP and Gilead Deal

Hong Kong Hong Kong SAR Gilead Sciences Encequidar Health Hope Pharma
Hanmi and Gilead Partnership

Hanmi and Gilead Partnership

South Korea Seoul Gilead Sciences Hanmi Pharm Encequidar
Gilead Selects Veeva

Gilead Selects Veeva

United States Veeva Systems Pleasanton COVID-19 Gilead Sciences
Gilead and Veeva CRM

Gilead and Veeva CRM

USA Veeva Systems Foster City Vault CRM Gilead Sciences
Gilead and Veeva Partnership

Gilead and Veeva Partnership

USA healthcare technology Pleasanton Gilead Sciences Veeva Vault
Gilead Chooses Veeva

Gilead Chooses Veeva

USA Veeva Systems Pleasanton Vault CRM Gilead Sciences
Gilead and Veeva Team Up

Gilead and Veeva Team Up

USA Innovation Foster City Gilead Sciences Veeva Vault CRM
Gilead and Veeva Partnership

Gilead and Veeva Partnership

USA Veeva Systems Pleasanton Vault CRM Gilead Sciences
WACO's Still Here Experience

WACO's Still Here Experience

United States Los Angeles Gilead Sciences WACO Theater Center Still Here
Gilead Q2 Earnings Report

Gilead Q2 Earnings Report

USA Foster City Gilead Sciences Yeztugo Biktarvy
Gilead's CAR T-Docs

Gilead's CAR T-Docs

Japan Tokyo Gilead Sciences T-Cell Therapy Kite CAR T
Pomerantz Investigates Gilead

Pomerantz Investigates Gilead

United States New York Securities Fraud Pomerantz LLP Gilead Sciences
Gilead Sciences Investigation

Gilead Sciences Investigation

United States New York Securities Fraud Pomerantz LLP Gilead Sciences
Gilead Investor Alert

Gilead Investor Alert

USA New York Pomerantz LLP FDA Hold Gilead Sciences
Gilead Fraud Investigation

Gilead Fraud Investigation

USA Los Angeles Schall Law Firm Fraud Investigation Gilead Sciences
Pomerantz Investigates Gilead

Pomerantz Investigates Gilead

United States New York Securities Fraud Pomerantz LLP Gilead Sciences
Gilead Sciences Investigation

Gilead Sciences Investigation

United States New York Pomerantz LLP Gilead Sciences GS-1720
Pomerantz Gilead Alert

Pomerantz Gilead Alert

USA New York Pomerantz LLP Investor Alert Gilead Sciences
Gilead Sciences Investigation

Gilead Sciences Investigation

United States New York FDA Pomerantz LLP Gilead Sciences
Gilead Investigation

Gilead Investigation

United States New York Securities Fraud Pomerantz LLP Gilead Sciences
Hepatitis B Market Insights

Hepatitis B Market Insights

United States Las Vegas Hepatitis B Gilead Sciences VEMLIDY
Gilead Sciences Alert

Gilead Sciences Alert

United States New York Securities Fraud Pomerantz LLP Gilead Sciences
Oncology Navigation Grant Launch

Oncology Navigation Grant Launch

USA Gainesville Gilead Sciences AONN+ Oncology Navigation
Gilead Q1 2025 Report

Gilead Q1 2025 Report

USA Foster City Trodelvy Gilead Sciences Veklury
Trodelvy Approval

Trodelvy Approval

Japan Tokyo Trodelvy Gilead Sciences HR+/HER2-
Patient-Centered Cancer Care

Patient-Centered Cancer Care

United States Michigan Gilead Sciences Patient Insight MOQC
TransCelerate's 2024 Report

TransCelerate's 2024 Report

United States Philadelphia TransCelerate BioPharma Gilead Sciences Robert Metcalf

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.